pinoresinol diglucoside has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, G; Lei, Y; Yao, X; Yi, J; Zhang, Y | 1 |
| Lei, S; Lei, X; Li, B; Liu, B; Wang, G; Wu, S | 1 |
| Chen, Y; Fu, X; Guo, J; Liang, T; Pan, R; Sun, T; Wang, L; Zhang, J; Zhang, L | 1 |
3 other study(ies) available for pinoresinol diglucoside and Disease Models, Animal
| Article | Year |
|---|---|
Pinoresinol diglucoside alleviates ischemia/reperfusion-induced brain injury by modulating neuroinflammation and oxidative stress.
Topics: Animals; Brain; Brain Ischemia; Cytokines; Disease Models, Animal; Heme Oxygenase-1; Lignans; Male; Membrane Proteins; Mice, Inbred C57BL; Middle Cerebral Artery; Neuroinflammatory Diseases; Neurons; NF-E2-Related Factor 2; Oxidative Stress; Reperfusion Injury | 2021 |
Pinoresinol diglucoside attenuates neuroinflammation, apoptosis and oxidative stress in a mice model with Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Catalase; Disease Models, Animal; Hippocampus; Inflammation; Injections; Interleukin-1beta; Lignans; Malondialdehyde; Mice; Morris Water Maze Test; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Stereotaxic Techniques; Superoxide Dismutase; Toll-Like Receptor 4; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2021 |
Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Topics: Animals; Animals, Newborn; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Fibrosis; Inflammation; Isoproterenol; Lignans; Male; Myocytes, Cardiac; NF-kappa B; Phenylephrine; Pressure; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2021 |